Chen Y - Search Results

1

A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p.G228D) from a large Chinese family.

Cui C, Zhang L, Qian F, Chen Y, Huang B, Wang F, Wang D, Lv J, Wang X, Yan Z, Guo L, Li GL, Shu Y, Liu D, Li H. Cui C, et al. Among authors: chen y. Clin Genet. 2022 Aug;102(2):149-154. doi: 10.1111/cge.14164. Epub 2022 May 28. Clin Genet. 2022. PMID: 35599357

2

Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing loss.

Cui C, Wang D, Huang B, Wang F, Chen Y, Lv J, Zhang L, Han L, Liu D, Chen ZY, Li GL, Li H, Shu Y. Cui C, et al. Among authors: chen zy, chen y. Mol Ther Nucleic Acids. 2022 Jul 20;29:400-412. doi: 10.1016/j.omtn.2022.07.016. eCollection 2022 Sep 13. Mol Ther Nucleic Acids. 2022. PMID: 36035752 Free PMC article.

3

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing.

Zheng Z, Li G, Cui C, Wang F, Wang X, Xu Z, Guo H, Chen Y, Tang H, Wang D, Huang M, Chen ZY, Huang X, Li H, Li GL, Hu X, Shu Y. Zheng Z, et al. Among authors: chen zy, chen y. Signal Transduct Target Ther. 2022 Mar 14;7(1):79. doi: 10.1038/s41392-022-00893-4. Signal Transduct Target Ther. 2022. PMID: 35283480 Free PMC article.

4

Structural insights into the lipid and ligand regulation of a human neuronal KCNQ channel.

Zheng Y, Liu H, Chen Y, Dong S, Wang F, Wang S, Li GL, Shu Y, Xu F. Zheng Y, et al. Among authors: chen y. Neuron. 2022 Jan 19;110(2):237-247.e4. doi: 10.1016/j.neuron.2021.10.029. Epub 2021 Nov 11. Neuron. 2022. PMID: 34767770 Free article.

5

Two hits are better than one: synergistic anticancer activity of α-helical peptides and doxorubicin/epirubicin.

Zhao J, Huang Y, Liu D, Chen Y. Zhao J, et al. Among authors: chen y. Oncotarget. 2015 Jan 30;6(3):1769-78. doi: 10.18632/oncotarget.2754. Oncotarget. 2015. PMID: 25593197 Free PMC article.

6

In vitro Characterization of the Rapid Cytotoxicity of Anticancer Peptide HPRP-A2 through Membrane Destruction and Intracellular Mechanism against Gastric Cancer Cell Lines.

Zhao J, Hao X, Liu D, Huang Y, Chen Y. Zhao J, et al. Among authors: chen y. PLoS One. 2015 Sep 30;10(9):e0139578. doi: 10.1371/journal.pone.0139578. eCollection 2015. PLoS One. 2015. PMID: 26422386 Free PMC article.

7

Novel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway.

Wang Y, Zhang B, Huang Y, Yao W, Tao F, Chen Y. Wang Y, et al. Among authors: chen y. Molecules. 2021 Jun 26;26(13):3915. doi: 10.3390/molecules26133915. Molecules. 2021. PMID: 34206871 Free PMC article.

8

Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability.

Hu C, Chen X, Huang Y, Chen Y. Hu C, et al. Among authors: chen x, chen y. Sci Rep. 2018 Feb 2;8(1):2274. doi: 10.1038/s41598-018-20715-4. Sci Rep. 2018. PMID: 29396568 Free PMC article.

9

Research on the effect and mechanism of antimicrobial peptides HPRP-A1/A2 work against Toxoplasma gondii infection.

Liu R, Ni Y, Song J, Xu Z, Qiu J, Wang L, Zhu Y, Huang Y, Ji M, Chen Y. Liu R, et al. Among authors: chen y. Parasite Immunol. 2019 May;41(5):e12619. doi: 10.1111/pim.12619. Epub 2019 Mar 12. Parasite Immunol. 2019. PMID: 30788848

10

Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway.

Liu J, Huang Y, Liu Y, Chen Y. Liu J, et al. Among authors: chen y. Med Sci Monit. 2019 Aug 14;25:6085-6096. doi: 10.12659/MSM.917625. Med Sci Monit. 2019. PMID: 31412018 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176,775 results

Search Page

Filters